9-valent HPV Vaccine in Postpartum Women
NCT04311528 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2020-03-17
Summary
This study will evaluate the immunogenicity of the 9-valent HPV vaccine in post-partum women age 16-45.
Conditions
Interventions
- BIOLOGICAL
-
9-valent HPV vaccine
9-valent HPV vaccine
Sponsors & Collaborators
-
Augusta University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
- FDA Drug
- Yes
More Related Trials
-
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
NCT03158220 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9
NCT03431246 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old
NCT05329961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
NCT03900572 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
NCT05496231 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
NCT06229353 ·Status: TERMINATED
-
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
NCT07281677 ·Status: RECRUITING ·Phase: PHASE4
-
Study on the Epidemiological Characteristics of Female HPV Vaccination in China
NCT05932563 ·Status: UNKNOWN
-
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
NCT00128661 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls
NCT04920526 ·Status: UNKNOWN
-
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
NCT04910802 ·Status: RECRUITING ·Phase: PHASE4
-
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
NCT01030562 ·Status: COMPLETED
-
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT03206255 ·Status: COMPLETED
-
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
NCT05371353 ·Status: RECRUITING
-
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)
NCT00090220 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
NCT02888418 ·Status: UNKNOWN ·Phase: PHASE1
-
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
NCT00092521 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)
NCT00517309 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)
NCT00834106 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)
NCT04708041 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine
NCT02968420 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
NCT00306241 ·Status: COMPLETED ·Phase: PHASE3
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA